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PURPOSE. The effects of the anti-cholinesterase organo-
phosphate pesticide chlorpyrifos (CPF) on the refractive
development of the eye were examined. Form deprivation
was used to induce eye growth to address the previously
reported relationship between organophosphate pesticide
use and the incidence of myopia.
METHODS. Chickens, a well-established animal model for
experimental myopia and organophosphate neurotoxic-
ity, were dosed with chlorpyrifos (3 mg/kg per day, orally,
from day 2 to day 9 after hatching) or corn oil vehicle
(VEH) with or without monocular form deprivation (MFD)
over the same period. The set of dependent measures
included the refractive state of each eye measured using
retinoscopy, axial dimensions determined with A-scan ul-
trasound, and intraocular pressure.
RESULTS. Dosing with CPF yielded an inhibition of 35%
butyrylcholinesterase in plasma and 45% acetylcholines-
terase in brain. MFD resulted in a significant degree of
myopia in form-deprived eyes resulting from significant
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lengthening of the vitreal chamber of the eye. CPF
significantly reduced the effect of MFD, resulting in less
myopic eyes (mean refraction: VEH-MFD = —16.2 ± 2.3
diopters; CPF-MFD = -11.1 ± 1.8 diopters) with sig-
nificantly shorter vitreal chambers. Nonoccluded eyes
were, on average, slightly hyperopic. Treatment with
CPF for 1 week in the absence of MFD led to no
significant change in ocular dimensions or refraction
relative to controls.
CONCLUSIONS. The use of form deprivation as a challenge
suggests that CPF treatment interferes with the visual
regulation of eye growth. (Invest Ophthalmol Vis Set.
1998;39:1290-1294)
A n epidemic of ocular toxicity reported in agricultural re-
jLjLgions of Japan during the late 1950s, 1960s, and 1970s was
attributed to heavy regional use of organophosphate insecti-
cides.1 A high incidence of myopia was prominent among a
variety of other visual symptoms and classical cholinergic signs
and symptoms. Subsequent experimental studies in Japan re-
ported degeneration of the retina, optic nerve, and extraocular
muscles in addition to myopia.1 The Japanese reports are
controversial, however, because similar cases of ocular toxicity
have not been reported elsewhere, and many of the Japanese
reports do not meet currently accepted standards of experi-
mental design, methodology, and reporting of results. In sup-
port of the Japanese findings, retinal and optic nerve lesions
have been seen after the feeding of organophosphate pesti-
cides to rats in studies reported to the US Environmental
Protection Agency by pesticide manufacturers.2 In addition, a
variety of biochemical, neuropathologic, and electrophysiolog-
ical changes have been noted in the retina and optic nerve of
adult rats treated with the organophosphate pesticide fen-
thion.23 To date, we know of no investigations outside of the
early Japanese reports that address the issue of myopia after
developmental organophosphate pesticide exposure.
The study of experimental myopia has shown that the
growth of the axial length of the eye is governed by visual
input and that a cholinergic system is involved in the regulation
of this process.4'5 Deprivation of patterned visual input during
development results in an increased axial length of the eye
(i.e., axial myopia).6 Treatment with the muscarinic blocking
agents atropine or pirenzepine prevents the development of
experimental axial myopia independent of effects on accom-
modation, implicating retinal processes.5'7 Areas of local pat-
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tern deprivation produce areas of focal ocular elongation, sug-
gesting that cholinergically mediated local trophic factors may
be involved in governing the growth of the length of the eye.8
Chlorpyrifos (CPF; O,O-diethyl-O-(3,5,6-trichloro-2-pyri-
dyl)phosphorothioate) is an organophosphate insecticide and
is present in many pesticide formulations that are commonly
used for household and agricultural applications. Exposure to
sufficient dose levels of CPF (like other organophosphate pes-
ticides) causes inhibition of blood and nervous system cho-
linesterase (ChE) activity, with accompanying cholinergic
signs. Although the acute effects of inhibition of ChE enzymes
in adult animals are generally considered to be reversible and
without long-term consequences, concern has arisen recently
regarding developmental exposure to pesticides.9
The present study investigates the effects of treatment
with CPF on the development of the chick eye. In addition to
CPF administration, some of the subjects were treated with
monocular pattern deprivation to serve as a positive control for
the measures of ocular dimensions, and also to study the
influence of CPF on the visual regulation of ocular growth. It
was hypothesized that the cholinergic effects of CPF treatment
would interfere with the development of the eye and produce
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FIGURE 1. (A) Chlorpyrifos (CPF) significantly inhibited cho-
linesterase (ChE) activity in plasma (t4A = 3.10, P < 0.003) and
whole brain (t41 = 6.39, P < 0.0001). ChE activity is expressed
as a percentage of control. Statistics compared all CPF-dosed
animals with all corn oil vehicle (VEH)-dosed animals. Control
activity was calculated as the mean of VEH-monocular form
deprivation (MFD) and VEH-Open groups. The treated animals
showed no overt cholinergic signs, for example, tremor, diar-
rhea. VEH, open bar; CPF, shaded bars. (B) The CPF-dosed
chicks were slightly, though significantly, lighter than the con-
trol chicks and gained weight more slowly than the controls
(treatment effect: F, 50 = 6.33, P < 0.02; day x treatment:
F6,3oo = 4-08, P <0.001).
METHODS
One-day-old broiler chicks (Arbor X Acre), received from the
North Carolina State University Poultry Research Farm (Ra-
leigh, NC), were housed in the vivarium of the Duke University
Medical Center. All aspects of the animal care and use were
conducted in compliance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research. On arrival, the
chicks were placed in a mesh-bottomed box brooder (G.Q.F.
Manufacturing, Savannah, GA) at a temperature of 37.8°C.
Chicks were housed under fluorescent light on a 12-hour light,
12-hour dark cycle and fed tap water and chick starter food
(Ralston Purina, St. Louis, MO) ad libitum.
Treatment of the chicks began on day 2 after hatching and
continued for 7 days. The chicks were divided into four
groups: two receiving the test compound CPF (Dow Elanco,
Midland, MI) and two receiving corn oil vehicle (VEH) only, 2
ml/kg. CPF was dissolved in corn oil and delivered at a dose of
3 mg/kg per day, 2 ml/kg, by oral gavage. This dose is approx-
imately 10% of the acute oral LD50 for young chicks as deter-
mined in pilot work. The oral route of exposure was selected
instead of intravitreal injections, a route sometimes used in
pharmacologic investigations of experimental myopia, because
the oral route is more toxicologically relevant and also because
CPF must be metabolically activated to chlorpyrifos-oxon by
microsomal enzymes in the liver to become a potent inhibitor
of acetylcholinesterase (AChE).
One VEH group and one CPF group were selected for
monocular form deprivation (MFD). Three cohorts of chicks
were run to produce the following group sizes: VEH-MFD,
n = 13; VEH-OPEN, n = 14; CPF-MFD, n = 14; and CPF-OPEN,
n = 13.
Form deprivation was accomplished using translucent
plastic domes 6 mm in height constructed from 12-mm diam-
eter, round-bottomed, polypropylene test tubes, attached over
one eye of each chick in the MFD groups using a cyanoacrylate
adhesive. These occluders diffused light and degraded pattern
vision. The occluders contained two small triangular notches
to allow ventilation of the eye. MFD was maintained for a
period of 1 week, concurrent with dosing.
Ocular Measurements. The animals were examined
with a battery of ocular tests on the day after the final treat-
ment with CPF or VEH. Anesthesia was induced with 50 mg/kg
ketamine (Ketaset; Fort Dodge Laboratories, Fort Dodge, IA)
and 35 mg/kg xylazine (American Animal Health, Wisner, NE)
anesthetic (intramuscularly, 1 ml/kg injection volume), after
which the occluders were removed. The animals were as-
sessed for refractive error without cycloplegia using streak
retinoscopy (Welch Allyn, Skaneateles Falls, NY). No correc-
tion was made for the small eye artifact of retinoscopy.10
Ocular dimensions of the chicks were measured using A-scan
ultrasonography (Echorule Biometer; 3M, Canada) under
"aphakic" mode, which used an effective conduction velocity
of 1548 m/sec for the whole eye. The ultrasound output
yielded measures of anterior chamber depth, lens thickness,
and vitreal chamber depth. Three ultrasound measurements
were taken for each eye, and the mean was used for further
data analysis.
Intraocular pressure (IOP) was measured (Tono-pen XL;
Mentor, Norwell, MA) in each eye. For IOP, eyelids were gently
manually retracted and the covered applanator was brought
into perpendicular contact with die central cornea. Readings
were taken until the device recorded four valid readings with
a 5% or better statistical reliability. In some cases no reading
was possible because of the small size of the eye.
ChE Inhibition. At the end of the experiments, the animals
were anesthetized using 0.25% halothane and eudianatized (ap-
proximately 24 hours after the final dose). Brains were rapidly
removed and homogenized (10% wt/vol) in 50 mM Tris-HCl
buffer, pH 8.0, with 0.1 mM EDTA. Blood samples were collected
into heparinized tubes and centrifuged at 4°C to separate plasma
and red blood cells. ChE activities in plasma and brain homoge-
nates were determined by the method of Ellman et al.'' Because
the majority of ChE activity in chicken plasma is butyrylcholines-
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FIGURE 2. (A) Mean refractions from open and occluded eyes of
chicks that underwent monocular form deprivation (MFD). MFD
resulted in extreme myopia (F1 1 0 2 = 190.91, P < 0.0001). The
chlorpyrifos (CPF>treated chicks (shaded bar) were significantly
less myopic than controls (open bar) (group X occlusion inter-
action, F, 102 = 6.38, P < 0.013; corn oil vehicle [VEH]-MFD
versus CPF-MFD: t25 = 330, P < 0.0013). There was no effect of
dosing on the unoccluded (open) eyes in the MFD animals. Re-
fractions from the unoccluded groups were not significantly dif-
ferent from the open eyes of controls (data not shown). (B) There
was no significant difference in length of the anterior chamber or
lens thickness caused by MFD or treatment with CPF measured
with A-scan ultrasound. (C) The vitreal chamber lengthened sig-
nificantly because of form deprivation (F, 102 = 68.02, P <
0.0001); elongation was significantly reduced in the CPF-treated
animals (shaded bars) compared with controls (open bars) (t25 =
2.024, P < 0.046). Axial measurements from the unoccluded
groups were not significantly different from the open eyes of
controls (data not shown).
terase, butyrylthiocholine (0.2 mM) was used as the substrate for
testing the plasma. For brain, the predominant ChE enzyme is
AChE. Therefore, acetylthiocholine (0.2 mM) was used as the
substrate. It should be noted, however, that acetylthiocholine is
not specific for AChE activity and that activity numbers may
reflect contributions of activity by the other forms of ChE. Protein
concentrations for brain and plasma were determined using die
bicinchoninic acid method.12 Enucleated eyes were immersion
fixed in 10% buffered formalin and processed routinely for light
microscopy.
Statistical Analyses. Ultrasound and refraction data were
analyzed using a two-way analysis of variance (treatment, oc-
clusion) to examine the main effects and interactions, and
least-squared means Mest for breakout paired comparisons of
specific groups (GLM procedure; SAS Institute, Cary, NC).
Body weight was analyzed using a repeated-measures analysis
of variance (treatment, day; GLM procedure). ChE inhibition




The dose of 3 mg/kg per day CPF significantly reduced ChE
activity in plasma (65.5% of control) and whole brain (56.5% of
control) (Fig. 1A). The treated animals showed no overt cho-
linergic signs, for example, tremor, diarrhea, pupillary miosis.
The CPF-dosed chicks were slightly, though significantly,
lighter than the control chicks and gained weight more slowly
than the controls (Fig. IB). This difference in body weight has
not been replicated in subsequent experiments with the same
dose of CPF.
Refraction
The occluded eyes refracted significantly more myopic than
the unoccluded eyes, producing —16.15 ± 2.30 diopters (D)
(SEM) of myopia in the VEH-MFD controls and -11.11 ± 1.84
D in the CPF-MFD group (Fig. 2A). The occluded eyes from the
CPF-MFD group were significantly less myopic than the VEH-
MFD eyes.
The unoccluded eyes measured slightly hyperopic, on
average. There was no significant difference in refraction be-
tween groups for the unoccluded eyes.
Ultrasound
MFD produced significant increases in axial length (F, 102 =
52.68, P < 0.0001). There were no significant differences
caused by occlusion or treatment in anterior chamber length or
lens thickness (Fig. 2B). The effect of MFD can be seen in the
increase in vitreal chamber depth (Fig. 2C). There was a sig-
nificant difference between the length of the vitreal chamber
in the MFD eyes of the VEH and CPF groups. The vitreal
chamber of the VEH-MFD group (6.27 ± 0.07 mm) was signif-
icantly longer than the CPF-MFD group (6.05 ± 0.09 mm).
Histology and Intraocular Pressure
IOP for the VEH-MFD animals was a mean of 9.25 mm Hg
±1.07 (SEM) in the unoccluded eyes compared with 10.58 ±
1.58 mm Hg in the occluded eye. In the CPF-MFD chicks, the
unoccluded eyes had a mean IOP of 10.07 ± 1.00 mm Hg
compared with 12.14 ± 0 9 3 mm Hg in the occluded eyes.
None of these differences were statistically significant. Light
microscopy demonstrated no differences between treatment
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groups, with scleral, ciliary muscle, and retinal morphology
unaffected by occlusion or CPF treatment.
DISCUSSION
The experiment reported here investigated whether treatment
with the organophosphate pesticide CPF could alter ocular
development in an experimental model of myopia. One week
of form deprivation with translucent diffusers produced a mea-
surable myopic state in chicks. Contrary to the a priori hypoth-
esis, oral administration of the organophosphate pesticide CPF
yielded a reduction in form deprivation myopia. The occluded
eyes of the CPF group were shorter and had a less negative
refraction than the corresponding eyes in the VEH control
group. In the absence of form deprivation, a 1-week treatment
with CPF had no measurable effect on refraction or axial eye
dimensions.
The reduction of form deprivation myopia by CPF is sur-
prising, given that AChE inhibition should lead to an increase
in cholinergic activity, whereas cholinergic blockers atropine
and pirenzepine reduce form deprivation myopia.5'7 Subcon-
junctival injections of carbachol, a nonselective cholinergic
agonist, had no effect on form deprivation myopia,5 but there
was no independent indication in that study that the adminis-
tered dose was high enough to have had any ocular effect. This
kind of paradoxical effect is not unique to cholinergic com-
pounds, however. The eye has previously been demonstrated
to become more myopic or less myopic in response to admin-
istration of the same neuroactive compound depending on
dose.13
There is a discrepancy between the ability of CPF to alter
the growth of the occluded eye without changing the growth
of the open eye. In this, CPF is similar to many other pharma-
cologic treatments tested in conjunction with form depriva-
tion.5'71415 It is known that visual impairment alters refractive
eye growth. However, the lack of cholinergic signs and the
modest level of ChE inhibition in the present study suggest that
CPF was not delivered at a dose level high enough to produce
a major impairment of vision in the unoccluded eye. This
suggests that the undegraded visual input in the opened eye,
which has a powerful influence on the regulation of eye
growth, was sufficient to overcome whatever subtle effects, if
any, of CPF on vision. In contrast, the occluded eye, lacking
strong visual input, may have been more susceptible to mod-
ulating influences of the pesticide treatment.
One possibility is that the effects of CPF, metabolized into
chlopyrifos-oxon, are mediated through disruption of cholin-
ergic neurotransmission. AChE activity is found throughout the
chicken eye,1617 including the inner plexiform layer of the
retina.18 The inner plexiform layer is where other pharmaco-
logic agents that affect experimental myopia may also have
their effects.14 While no retinal ChE activity was determined
for these chicks, previous work on organophosphate pesti-
cides showed that ChE inhibition in rat brain and retina corre-
lated highly.3 Another possibility is that chlorpyrifos-oxon had
a direct effect, because it binds directly to M2 and M4 musca-
rinic receptors,19 but previous evidence points toward a role
for the Ml receptors alone in mediating form deprivation
myopia.5
Another alternative is that CPF may have produced the
observed effects through general toxicity, which impaired the
maximal possible rate of ocular growth. It should be consid-
ered, however, that no overt cholinergic signs were noted in
the CPF-dosed animals, nor were there signs of overt retinal
toxicity. Although the CPF-dosed animals weighed slightly less
than the VEH-dosed animals, it is unlikely that difference in
body size accounted for the difference in eye growth, given
that the axial length of eye structures in the unoccluded eyes
of the CPF groups and the comparable eyes of the VEH groups
did not differ. We also note that the observed difference in
body weight has not been replicated in subsequent experi-
ments in which a similar reduction of MFD was observed with
the same dosing regimen of CPF.
Refraction was done without cycloplegia. Spasm of ac-
commodation resulting from cholinergic action on the ciliary
muscle and pupillary miosis occur in poisoning by ChE inhib-
itors, yielding a more myopic refraction. Our data, however,
show the opposite. The occluded eyes of CPF-MFD chicks
were less myopic than the occluded eyes of VEH-MFD controls,
and no difference was observed between the unoccluded eyes.
In addition, biometry yielded no significant difference in lens
thickness between groups, suggesting that the accommodative
state was similar in treated and control groups. Finally, die lack
of overt signs of ChE inhibition along with the use of a systemic
anesthetic while taking the measurements suggest that spasm
of the accommodative muscles was unlikely.
The findings reported here demonstrate that CPF affects
eye growth in an experimental model of form deprivation
myopia. Form deprivation myopia is the expected response to
an idiosyncratic stimulus condition consisting of a visual image
blurred by translucent diffusers. As such, form deprivation can
be considered a challenge for which axial elongation is the
normal response. CPF partially inhibited the growth response
to form deprivation. Although there are well-documented lim-
itations in the applying the chicken model to human myopia,20
it is clear that in avian and mammalian species there are visually
regulated eye growth signals similarly affected by pattern de-
privation. Pharmacologic manipulations that modify eye
growth in birds also modify eye growth in mammals,21'22
suggesting that similar neurochemical modulators underlie reg-
ulation of eye growth across species.
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